Relay Therapeutics (NASDAQ:RLAY) Hits New 52-Week High on Analyst Upgrade

Relay Therapeutics, Inc. (NASDAQ: RLAY - Get Free Report) shares hit a new 52-week high during mid-day trading on Friday after Guggenheim raised their price target on the stock from $15.00 to $22.00. Guggenheim currently has a buy rating on the stock. Relay Therapeutics traded as high as $11.49 and last traded at $10.8950, with a